Medlive Technology Co., Ltd.

Symbol: 2192.HK

HKSE

8.6

HKD

Market price today

  • 24.0324

    P/E Ratio

  • -0.5882

    PEG Ratio

  • 6.25B

    MRK Cap

  • 0.02%

    DIV Yield

Medlive Technology Co., Ltd. (2192-HK) Stock Price & Analysis

Shares Outstanding

726.96M

Gross Profit Margin

0.61%

Operating Profit Margin

0.16%

Net Profit Margin

0.59%

Return on Assets

0.05%

Return on Equity

0.05%

Return on Capital Employed

0.01%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Distribution
CEO:Ms. Liping Tian
Full-time employees:742
City:Beijing
Address:E1, Red Mnr Intl. Bonded Innovation Park
IPO:2021-07-15
CIK:

Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, protocol design, medical monitoring, patient recruitment, and supporting system, as well as digital market research, electronic data capture, real-world studies, and application software development services. The company's medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies. Its intelligent patient management solution provides chronic disease management services, comprising online patient consultation, prescription services, and patient management through Internet hospital; and condition-specific patient education services, which includes content development, application software development, and other related services. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. Medlive Technology Co., Ltd. was founded in 1996 and is headquartered in Beijing, China.

General Outlook

In simple terms, Medlive Technology Co., Ltd. has 726.962 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.610% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.158%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.588%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.050% return, is a testament to Medlive Technology Co., Ltd.'s adeptness in optimizing resource deployment. Medlive Technology Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.053%. Furthermore, the proficiency of Medlive Technology Co., Ltd. in capital utilization is underscored by a remarkable 0.014% return on capital employed.

Stock Prices

Medlive Technology Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $7.44, while its low point bottomed out at $7.27. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Medlive Technology Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 2192.HK liquidity ratios reveals its financial health of the firm. The current ratio of 2409.52% gauges short-term asset coverage for liabilities. The quick ratio (2401.21%) assesses immediate liquidity, while the cash ratio (2296.57%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio2409.52%
Quick Ratio2401.21%
Cash Ratio2296.57%

Profitability Ratios

2192.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 61.44% underscores its earnings before tax deductions. The effective tax rate stands at 0.54%, revealing its tax efficiency. The net income per EBT, 95.72%, and the EBT per EBIT, 388.63%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 15.81%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin61.44%
Effective Tax Rate0.54%
Net Income per EBT95.72%
EBT per EBIT388.63%
EBIT per Revenue15.81%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 24.10, it details the span from stock purchase to revenue. The 24 days it takes to settle debts showcases its creditor relations. Meanwhile, a 23 cash conversion cycle and 264.24% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding2401
Operating Cycle138.36
Days of Payables Outstanding34
Cash Conversion Cycle105
Receivables Turnover2.64
Payables Turnover10.88
Inventory Turnover1622.92
Fixed Asset Turnover37.20
Asset Turnover0.08

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.14, and free cash flow per share, 0.14, depict cash generation on a per-share basis. The cash per share value, 6.01, showcases liquidity position. A payout ratio of 0.51 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.25, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.14
Free Cash Flow per Share0.14
Cash per Share6.01
Payout Ratio0.51
Operating Cash Flow Sales Ratio0.25
Free Cash Flow to Operating Cash Flow Ratio0.99
Cash Flow Coverage Ratio12.43
Short Term Coverage Ratio22.39
Capital Expenditure Coverage Ratio135.82
Dividend Paid and Capex Coverage Ratio0.81
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.17%, highlights its total liabilities relative to assets. The long-term debt to capitalization, 0.08%, and total debt to capitalization, 0.18%, ratios shed light on its capital structure. An interest coverage of 295.35 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio0.17%
Long Term Debt to Capitalization0.08%
Total Debt to Capitalization0.18%
Interest Coverage295.35
Cash Flow to Debt Ratio12.43
Company Equity Multiplier1.06

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.57, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.34, reflects the portion of profit attributed to each share. The book value per share, 6.37, represents the net asset value distributed per share, while the tangible book value per share, 6.08, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.57
Net Income Per Share0.34
Book Value Per Share6.37
Tangible Book Value Per Share6.08
Shareholders Equity Per Share6.37
Interest Debt Per Share0.01
Capex Per Share-0.05

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 31.19%, indicates top-line expansion, while the gross profit growth, 18.14%, reveals profitability trends. EBIT growth, -51.79%, and operating income growth, -51.79%, offer insights into operational profitability progression. The net income growth, 106.53%, showcases bottom-line expansion, and the EPS growth, 112.50%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth31.19%
Gross Profit Growth18.14%
EBIT Growth-51.79%
Operating Income Growth-51.79%
Net Income Growth106.53%
EPS Growth112.50%
EPS Diluted Growth106.25%
Weighted Average Shares Growth1.05%
Weighted Average Shares Diluted Growth-0.26%
Dividends per Share Growth916.99%
Operating Cash Flow Growth31.97%
Free Cash Flow Growth-0.52%
10-Year Revenue Growth per Share371.94%
5-Year Revenue Growth per Share371.94%
3-Year Revenue Growth per Share84.47%
10-Year Operating CF Growth per Share340.85%
5-Year Operating CF Growth per Share340.85%
3-Year Operating CF Growth per Share-12.30%
10-Year Net Income Growth per Share1532.60%
5-Year Net Income Growth per Share1532.60%
3-Year Net Income Growth per Share171.90%
10-Year Shareholders Equity Growth per Share12472.99%
5-Year Shareholders Equity Growth per Share12472.99%
3-Year Shareholders Equity Growth per Share2802.81%
Receivables Growth25.53%
Inventory Growth-50.25%
Asset Growth6.31%
Book Value per Share Growth3.38%
Debt Growth-27.26%
R&D Expense Growth17.36%
SGA Expenses Growth17.12%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,196,908,567.653, captures the company's total value, considering both debt and equity. Income quality, 0.40, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.35, gauges operational efficiency, while the research and development to revenue, 13.17%, highlights investment in innovation. The ratio of intangibles to total assets, 5.30%, indicates the value of non-physical assets, and capex to operating cash flow, -31.93%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value1,196,908,567.653
Income Quality0.40
Sales General and Administrative to Revenue0.35
Research and Development to Revenue13.17%
Intangibles to Total Assets5.30%
Capex to Operating Cash Flow-31.93%
Capex to Revenue-7.89%
Capex to Depreciation-347.09%
Stock-Based Compensation to Revenue2.53%
Graham Number6.93
Return on Tangible Assets5.23%
Graham Net Net5.91
Working Capital4,382,816,000
Tangible Asset Value4,385,941,000
Net Current Asset Value4,323,974,000
Average Receivables140,065,500
Average Payables8,740,000
Average Inventory149,000
Days Sales Outstanding138
Days Payables Outstanding34
ROIC1.40%
ROE0.05%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.27, and the price to book ratio, 1.27, reflect the market's valuation relative to the company's book value. The price to sales ratio, 14.04, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 57.21, and price to operating cash flows, 57.16, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.27
Price to Book Ratio1.27
Price to Sales Ratio14.04
Price Cash Flow Ratio57.16
Price Earnings to Growth Ratio-0.59
Enterprise Value Multiple146.78
Price Fair Value1.27
Price to Operating Cash Flow Ratio57.16
Price to Free Cash Flows Ratio57.21
Price to Tangible Book Ratio1.21
Enterprise Value to Sales2.91
Enterprise Value Over EBITDA4.57
EV to Operating Cash Flow11.75
Earnings Yield4.37%
Free Cash Flow Yield1.25%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Medlive Technology Co., Ltd. (2192.HK) on the HKSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 24.032 in 2024.

What is the ticker symbol of Medlive Technology Co., Ltd. stock?

The ticker symbol of Medlive Technology Co., Ltd. stock is 2192.HK.

What is company IPO date?

IPO date of Medlive Technology Co., Ltd. is 2021-07-15.

What is company current share price?

Current share price is 8.600 HKD.

What is stock market cap today?

The market cap of stock today is 6251873200.000.

What is PEG ratio in 2024?

The current -0.588 is -0.588 in 2024.

What is the number of employees in 2024?

In 2024 the company has 742.